Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.
Other companies in Myriad Genetics’s space includes: Zura Bio Ltd (NASDAQ:ZURA), Tectonic Therapeutic Inc (NASDAQ:TECX), 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Valneva SE (NASDAQ:VALN) and Larimar Therapeutics Inc (NASDAQ:LRMR).
Myriad Genetics has a consensus price target of $14.34.
The stock price for Myriad Genetics (NASDAQ: MYGN) is $4.99 last updated April 21, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Myriad Genetics.
Myriad Genetics does not have any upcoming earnings scheduled.
There is no upcoming split for Myriad Genetics.
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.